047920.KQ
HLB Pharmaceutical Co., Ltd
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,640.00
+3.66%Margins
Gross margin
44.8%
EBITDA margin
2.5%
EBIT margin
0.7%
Net margin
1.1%
FCF margin
-1.7%
2.1%
Return on equity
1.5%
Return on assets
1.2%
Return on invested capital
1.32x
Asset turnover
KRW 4.3B
Cash from operations
KRW 582
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026